BiOptic Inc. Chairman Shou-Guan Tsai stated yesterday that this year would be a transformative year for the group's operations, expanding into three major applications: scientific research, genetic testing, and clinical diagnostics. The group will leverage its resources to expand into point-of-care testing (POCT), liquid biopsy, as well as everyday life applications such as food safety, pet pathogens, and nucleic acid identification. This aims to establish a comprehensive health gene testing and preventive medicine group
Read more
